Welcome to our dedicated page for Scientific Ind SEC filings (Ticker: SCND), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Scientific Industries, Inc. (SCND) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Scientific Industries is a life science tool provider and manufacturer of DOTS bioprocessing systems, VIVID vision-based pill counters, and Torbal weighing products, and its filings offer detailed insight into how these operations are reflected in its financial statements and governance.
Investors can review periodic reports such as Forms 10-K and 10-Q, which include audited and unaudited financial statements, segment information for Benchtop Laboratory Equipment Operations and Bioprocessing Systems Operations, and management’s discussion of factors affecting revenues and margins. For example, the company’s communications reference trends in Torbal Division sales, Bioprocessing Systems revenue softness, and the effects of tariffs and customer budgets, topics that are typically expanded upon in its quarterly and annual reports.
This page also surfaces current reports on Form 8-K, including the 8-K/A describing the Asset Purchase Agreement under which Scientific Industries sold substantially all assets of its Genie Division to Troemner, LLC. Such filings outline material definitive agreements, completion of asset sales, and related pro forma financial information. Notifications of late filing, such as the NT 10-Q for the quarter ended September 30, 2025, are also part of the company’s SEC record and explain timing of certain reports.
In addition, users can access proxy materials like the Definitive Proxy Statement on Schedule 14A, which covers matters for shareholder votes, including director elections, amendments to equity incentive plans, and ratification of the independent registered public accounting firm. Stock Titan enhances these documents with AI-powered summaries that highlight key points from lengthy filings, helping readers quickly identify important disclosures about Scientific Industries’ capital structure, governance, and strategic transactions while retaining the ability to consult the full original filings.
Scientific Industries, Inc. (SCND) received an Amendment No. 4 to Schedule 13G from North Run entities and affiliates reporting beneficial ownership of 1,189,632 shares of common stock, equal to 9.99% of the class.
The reported amount includes 835,000 common shares and 354,632 warrants that are exercisable within 60 days. As of September 30, 2025, the reporting group held an aggregate of 920,000 warrants, but only 354,632 are currently exercisable due to beneficial ownership limitations. The percentage was calculated using 11,553,599 shares outstanding as of August 19, 2025.
The reporting persons have shared voting and dispositive power over the 1,189,632 shares and no sole power. They certified the securities were not acquired for the purpose of changing or influencing control.
Scientific Industries, Inc. (SCND) reporting person John J. Nicols, a director, exercised 15,000 warrants on
John A. Moore, Chairman and Director of Scientific Industries Inc. (SCND), reported a personal purchase of 5,800 shares of the company's common stock on 09/17/2025 at a price of $0.70 per share. After the transaction he beneficially owned 467,089 shares. The Form 4 was signed by John Moore on 09/18/2025 and was filed as a single reporting person disclosure.
Director John A. Moore purchased 9,599 shares of Scientific Industries Inc. (SCND) on 09/16/2025 at $0.64 per share. After the transaction he beneficially owns 461,289 shares. The Form 4 indicates the filing was signed on 09/18/2025 and identifies Moore as a company director. No derivative transactions or other securities changes are reported.